Predictive Oncology
Stock Forecast, Prediction & Price Target
Predictive Oncology Financial Estimates
Predictive Oncology Revenue Estimates
Predictive Oncology EBITDA Estimates
Predictive Oncology Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $1.42M N/A | $1.50M 5.96% | $1.78M 18.24% | Avg: $113.2M Low: $113.2M High: $113.2M avg. 6259.21% | |||
Net Income
% change YoY
| $-19.65M N/A | $-36.20M -84.19% | $-13.98M 61.37% | Avg: $28.10M Low: $28.10M High: $28.10M avg. 300.97% | |||
EBITDA
% change YoY
| $-6.67M N/A | $-3.30M 50.52% | $-13.18M -298.92% | Avg: $-84.07M Low: $-84.07M High: $-84.07M avg. -537.81% | |||
EPS
% change YoY
| -$7.16 N/A | -$9.92 -38.54% | -$3.48 64.91% | Avg: $7 Low: $7 High: $7 avg. 301.14% | |||
Operating Expenses
% change YoY
| $14.40M N/A | $16.26M 12.93% | $15.12M -7.00% | Avg: $939.54M Low: $939.54M High: $939.54M avg. 6110.14% |
FAQ
What is Predictive Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 300.97% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is 28.10M, average is 28.10M and high is 28.10M.
What is Predictive Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6259.21% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $113.2M, average is $113.2M and high is $113.2M.
What is Predictive Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 301.14% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is $7, average is $7 and high is $7.